Gainers
Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Sarcos Technology (NASDAQ:STRC) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. The company reported quarterly sales of $1.13 million which missed
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
Jefferies analyst Stephen Volkmann initiated coverage of industrial robotics company Sarcos Technology & Robotics Corp (NASDAQ:STRC) with a Buy rating and $16 price…